Skip to content

Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde

C20H25N5O4 — CID 142573619

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde
SMILESCOC.O=CN1CCC(c2nc(-c3ccc4cnn(C5COC5)c4c3)no2)CC1
InChIInChI=1S/C18H19N5O3.C2H6O/c24-11-22-5-3-12(4-6-22)18-20-17(21-26-18)13-1-2-14-8-19-23(16(14)7-13)15-9-25-10-15;1-3-2/h1-2,7-8,11-12,15H,3-6,9-10H2;1-2H3
InChIKeyCASBWUUHLMYUEO-UHFFFAOYSA-N
MW399.45 g/mol
LogP2.26
Rot. Bonds4

About Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde

Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde (PubChem CID 142573619) has the molecular formula C20H25N5O4 and a molecular weight of 399.45 g/mol. Its IUPAC name is methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde.

Molecular Properties

Compound NameMethoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde
PubChem CID142573619
Molecular FormulaC20H25N5O4
Molecular Weight399.45 g/mol
Exact Mass399.19
IUPAC Namemethoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde
SMILESCOC.O=CN1CCC(c2nc(-c3ccc4cnn(C5COC5)c4c3)no2)CC1
InChIInChI=1S/C18H19N5O3.C2H6O/c24-11-22-5-3-12(4-6-22)18-20-17(21-26-18)13-1-2-14-8-19-23(16(14)7-13)15-9-25-10-15;1-3-2/h1-2,7-8,11-12,15H,3-6,9-10H2;1-2H3
InChIKeyCASBWUUHLMYUEO-UHFFFAOYSA-N
XLogP2.26
TPSA95.51 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500399.45
LogP ≤ 52.26
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde?
The IUPAC name of Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde (CID 142573619) is methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde.
What is the SMILES notation for Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde?
The canonical SMILES for Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde is COC.O=CN1CCC(c2nc(-c3ccc4cnn(C5COC5)c4c3)no2)CC1.
What is the InChIKey of Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde?
The InChIKey is CASBWUUHLMYUEO-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H19N5O3.C2H6O/c24-11-22-5-3-12(4-6-22)18-20-17(21-26-18)13-1-2-14-8-19-23(16(14)7-13)15-9-25-10-15;1-3-2/h1-2,7-8,11-12,15H,3-6,9-10H2;1-2H3.
What are the key properties of Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde?
Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde has a molecular weight of 399.45 g/mol, XLogP of 2.26, 4 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for Methoxymethane;4-[3-[1-(oxetan-3-yl)indazol-6-yl]-1,2,4-oxadiazol-5-yl]piperidine-1-carbaldehyde is sourced from PubChem (CID 142573619), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.